Section I:Food Regulations and Standards——Session 3:Nutrition Policy |
2026-03-14 09:00-12:00 BFA,Dong Yu Grand Ballroom A |
| |
| 2026-03-14 09:00-09:30 National Nutrition Policies |
| 2026-03-14 09:30-10:00 Dietary Guidelines for Chronic Diseases Series |
| 2026-03-14 10:00-10:30 Key Tasks and Future Plans of the National Nutrition Plan for 2026Zhihong Wang Research Fellow,Deputy Director of,Institute of Nutrition and Health,Chinese Center for Disease Control and Prevention |
| 2026-03-14 10:30-11:00 Nutrition and Health Standards and Their Formulation DirectionZhang Bing Researcher,Deputy Director of the Institute of Nutrition and Health,Chinese Center for Disease Control and Prevention |
| 2026-03-14 11:00-11:30 Agricultural and Food Nutrition Policies and Standards |
| 2026-03-14 11:30-12:00 Roundtable Meeting:Healthy Food High-Quality Development Led by Nutrition Policies and StandardsModerator: |
Section II:New Technologies and New Products——Session 2:Efficacy and Evidence-Based Applications of Ergothioneine |
2026-03-14 09:00-12:00 Dongyu,Hesheng room(Wanquan Ballroom 1/3) |
Moderator:He Tao,Deputy Director,Key Laboratory of Food Nutrition and Health Evaluation Technology,State Administration for Market Regulation |
| 2026-03-14 09:00-09:20 Synthetic biology of ergothioneine in edible mushrooms and its anti-aging effects |
| 2026-03-14 09:20-09:40 Dr.Ergo® Ergothioneine:Re-establishing the Value of the 5th-Generation Smart Antioxidants Based on Clinical Evidence |
| 2026-03-14 09:40-10:00 Synergistic Inhibition of Acrolein Activity by Ergothioneine and GABA:In Vitro and In Vivo Studies |
| 2026-03-14 10:00-10:20 Redefining Dietary Supplements with Evidence-Based Science and Human Clinical Evidence |
| 2026-03-14 10:20-10:40 The protective effect of ergothioneine on oxidative damage of nerve cells |
| 2026-03-14 10:40-11:00 Ergothioneine:Efficacy Research and Regulatory Status |
| 2026-03-14 11:00-11:55 Roundtable Meeting:The Development Path of Ergothioneine in ChinaModerator: |
| 2026-03-14 11:55-12:00 |
Section II:New Technologies and New Products——Session 3:New Breakthroughs in HMOs Precision Nutrition and Its Diversified Population Applications |
2026-03-14 08:30-11:40 Dongyu,Yiyong room(Wanquan Ballroom 1/3) |
Moderators: |
| 2026-03-14 08:30-08:50 Chinese HMOs Profile:Research and Application |
| 2026-03-14 08:50-09:10 Regulatory Effects of HMOs on Glucose and Lipid Metabolism Disorders in Adults |
| 2026-03-14 09:10-09:30 The trends of regulatory management of HMOs |
| 2026-03-14 09:30-09:50 The Potential Application Value of HMOs in the Field of Healthy Aging |
| 2026-03-14 09:50-10:10 Research on the Effect of Human Milk Oligosaccharides on Brain Development |
| 2026-03-14 10:10-10:30 From the Wisdom of Breast Milk to Clinical Promise:HMOs and Probiotics in Synergy to Protect Preterm Infant Gut Health |
| 2026-03-14 10:30-10:50 The Effects of Multiple Human Milk Oligosaccharides and HMO-Based Combinations on Infant/Toddler Health and Neurocognitive Development:Evidence-Based Research and Future Innovation Pathways |
| 2026-03-14 10:50-11:10 Unlocking the Health Code of HMOs:Clinical Research Exploration and Practice by Synaura Bio |
| 2026-03-14 11:10-11:30 Global Trends in HMO Research and Applications |
| 2026-03-14 11:30-12:00 Roundtable Meeting:Risks of Biosynthetic Human Milk Oligosaccharides (HMOs) Applied in the Production of Infant and Toddler Formula Milk PowderModerator: |
Section VI:Probiotics,Prebiotics and Postbiotics——Postbiotics Session |
2026-03-14 09:00-11:00 BFA,Dong Yu Grand Ballroom C |
| |
| 2026-03-14 09:00-09:20 A Novel Fermented Oat with Postbiotic Effect:Design Strategies and Scientific Basis |
| 2026-03-14 09:20-09:40 Post LB Postbiotics and the Intestinal Barrier:Current Scientific Evidence and Novel Insights |
| 2026-03-14 09:40-10:00 Postbiotics Along the Gut–Brain Axis:LAC‑Living+ as a Clinically Evidenced Driver of New Growth in Emotional Well‑Being |
| 2026-03-14 10:00-10:20 New Randomized Controlled Trial Findings of Gastric-Derived Lactobacillus johnsonii LJ88 for Gastric Health |
| 2026-03-14 10:20-11:00 |